Skip to main content
Clinical Trials/NCT01266343
NCT01266343
Completed
Not Applicable

Comparison of Anterior Chamber Paracentesis and Conventional Mannitol Infusion in Patients With Primary Acute Angle-closure Glaucoma

Taipei Medical University WanFang Hospital1 site in 1 country60 target enrollmentJanuary 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Glaucoma
Sponsor
Taipei Medical University WanFang Hospital
Enrollment
60
Locations
1
Status
Completed
Last Updated
15 years ago

Overview

Brief Summary

The investigators wanted to reported the results of immediate anterior chamber paracentesis (ACP), compared to Mannitol infusion, in patients with acute primary angle-closure glaucoma (PACG). In this study, the investigators first divided patients into three sub-groups according to their initial intraocular pressure (IOP) for analyzing the differences of IOP control, severity of corneal edema, waiting time for laser peripheral iridotomy (LPI), and visual outcome between ACP and Mannitol infusion.

Detailed Description

The investigators demonstrated that ACP could be first considered in patients with initial IOP between 45 to 60 mmHg because it provided better visual outcome than Mannitol infusion through the rapid stabilization of the anterior segment, which was achieved by rapid IOP control, better corneal edema regression, shortening waiting time for LPI. However, ACP should be considered in patients with the initial IOP of 60mmHg and higher only when Mannitol was contraindicated.

Registry
clinicaltrials.gov
Start Date
January 2007
End Date
December 2009
Last Updated
15 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • first attack of acute PACG;
  • initial presenting IOP was higher than 45 mmHg;
  • diagnosis confirmed by gonioscopic examination;
  • patients within 48 hours of symptom onset.

Exclusion Criteria

  • been incompletely followed up within 2 weeks;
  • been using anti-glaucomatous medication before ACP or Mannitol infusion;
  • previous intraocular surgeries on the same eye;
  • contraindication for Mannitol;
  • history of other vision-threatening ocular diseases.

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials